Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
25.27
+0.58 (2.35%)
Aug 5, 2026, 10:16 AM EDT - Market open
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $2.62 billion as of August 5, 2026. Its market cap has increased by 210.73% in one year.
Market Cap
2.62B
Enterprise Value
2.18B
1-Year Change
210.73%
Ranking
Category
Stock Price
$25.27
ChartMarket Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $2.62B, an increase of 272.47%. That is a compound annual growth rate of 24.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 2.41B | 25.32% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.69B |
| AtaiBeckley | 2.65B |
| Tarsus Pharmaceuticals | 2.62B |
| Kodiak Sciences | 2.62B |
| Trevi Therapeutics | 2.60B |
| Ultragenyx Pharmaceutical | 2.48B |
| Nektar Therapeutics | 2.44B |
| Precigen | 2.38B |